Numeric Investors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Numeric Investors’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$12.5M	Buy	99,265 +1,893	+2%	+$242K	0.09%	211
2017 Q3	$13.3M	Buy	97,372 +59,654	+158%	+$7.98M	0.1%	182
2017 Q2	$5.38M	Buy	37,718 +35,140	+1,363%	+$5.43M	0.05%	327
2017 Q1	$474K	Sell	2,578 -6,466	-71%	-$725K	﹤0.01%	802
2016 Q4	$729K	Sell	9,044 -16,292	-64%	-$1.29M	0.01%	741
2016 Q3	$1.94M	Buy	+25,336	New	+$2.03M	0.02%	477
2016 Q2	–	Sell	-44,624	Closed	-$4.13M	–	1230
2016 Q1	$4.13M	Buy	+44,624	New	+$4.46M	0.04%	308
2015 Q4	–	Sell	-20,865	Closed	-$3.11M	–	1184
2015 Q3	$3.11M	Buy	20,865 +18,715	+870%	+$13.7M	0.04%	321
2015 Q2	$2.04M	Buy	+2,150	New	+$1.76M	0.02%	382
2015 Q1	–	Sell	-650	Closed	-$516K	–	1103
2014 Q4	$516K	Buy	+650	New	+$350K	0.01%	602
2014 Q1	–	Sell	-1,078	Closed	-$291K	–	942
2013 Q4	$291K	Buy	+1,078	New	+$257K	﹤0.01%	694

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Numeric Investors's TTPH Position: Q4 2017 in Review

Numeric Investors increased its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 1.9% in Q4 2017, buying an estimated $242K and bringing the position to 99,265 shares worth $12.5M. The position accounts for 0.09% of the portfolio, ranked #211.

Numeric Investors first reported a position in TTPH in Q4 2013 and has held it in 11 quarters since. The position peaked at $13.3M in Q3 2017. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

Numeric Investors held 99,265 shares of Tetraphase Pharmaceuticals, Inc. worth $12.5M as of Q4 2017.
Numeric Investors bought 1,893 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $242K.
Tetraphase Pharmaceuticals, Inc. made up 0.09% of Numeric Investors's portfolio in Q4 2017, its #211 holding.
Numeric Investors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and has held it in 11 quarters since.
Numeric Investors's Tetraphase Pharmaceuticals, Inc. position peaked at $13.3M in Q3 2017.
103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.